825 top medical experts on Liposarcoma across 31 countries and 36 U.S. states, including 769 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Liposarcoma: A malignant tumor derived from primitive or embryonal lipoblastic cells. It may be composed of well-differentiated fat cells or may be dedifferentiated: myxoid (liposarcoma, myxoid), round-celled, or pleomorphic, usually in association with a rich network of capillaries. Recurrences are common and dedifferentiated liposarcomas metastasize to the lungs or serosal surfaces. (From Dorland, 27th ed; Stedman, 25th ed)
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Adipose Tissue Neoplasms (293), Sarcoma (3,723) and Narrower Categories: Myxoid Liposarcoma (1,292).
  4. Clinical Trials ClinicalTrials.gov : at least 104 including 19 Active, 37 Completed, 25 Recruiting
  5. Synonyms: Dedifferentiated Liposarcoma,  Pleomorphic Liposarcoma


  

        

                    


    Computing Expert Listing ...

);